These are exciting times for therapeutic development for chronic neurodegenerative diseases. For Parkinson’s disease, there is now a test for a key Parkinson’s associated biomarker in the cerebrospinal fluid that can indicate disease pathology in the brain even before the clinical symptoms emerge. Importantly, it appears we may soon have a blood-based marker of brain pathology for early diagnosis.
This talk will highlight the current pipeline and the opportunities for developing medications that have the potential to slow the progression of Parkinson’s disease.
Our speaker, Dr. Kalpana Merchant, has been studying Parkinson’s disease biology to help develop therapeutics for more than 20 years. She is an advisor to the Michael J Fox Foundation for Parkinson’s research and other companies developing medicines for Parkinson’s and other neurodegenerative diseases.